Share

Unprecedented: How COVID-19 Jump-Started Diabetes Care Innovations

EN1120_cover-small The Endocrine Society has been leading the charge for adopting innovative diabetes care models since 2018. However, the specter of the COVID-19 pandemic has forced the entire healthcare industry to rethink how patients are treated, resulting in an unprecedented wave of innovation that could revolutionize how care is delivered. In early March, Robert A. Gabbay,...
Share

New Study: 80% of COVID-19 Patients Have Vitamin D Deficiency

jcem cover Over 80% of 200 COVID-19 patients in a hospital in Spain have vitamin D deficiency, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Vitamin D is a hormone the kidneys produce that controls blood calcium concentration and impacts the immune system. Vitamin D deficiency has been linked to a variety...
Share

COVID-19 Patients with Spinal Fractures Twice as Likely to Die

Patients with COVID-19 and vertebral fractures are twice as likely to die from the disease, according to a study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Vertebral fractures occur when the bony block or vertebral body in the spine collapses, which can lead to severe pain, deformity, and loss of height. These fractures are typically caused by osteoporosis (weak, brittle bones)....
Share

COVID-19 Drives Innovations in Diabetes Treatment and Care

The COVID-19 pandemic has jumpstarted innovation in healthcare delivery and allowed for real-world testing of diabetes care models in unprecedented ways, according to a manuscript published in The Journal of Clinical Endocrinology & Metabolism. For diabetes, which affects half a billion people worldwide, innovation has long been overdue. Currently, less than 50% of people with...
Share

COVID-19 and Subacute Thyroiditis: An Alert for Endocrinologists

A paper published in The Journal of Clinical Endocrinology & Metabolism sounds an alarm for clinicians treating COVID-19 patients to be on the lookout for possible cases of subacute thyroiditis post-infection. COVID-19 upended the world as we knew it in 2020, and its effects are continuing to be felt. New clinical sequelae are also emerging,...
Share

Bone Health Experts Issue Osteoporosis Treatment Guidance During COVID-19

As the COVID-19 pandemic became more serious, the Endocrine Society joined a coalition of bone health organizations that united to issue new osteoporosis treatment guidelines. Aside from addressing the challenges social distancing has placed on treating these patients, the coalition has also focused on the administration of osteoporosis medications including denosumab, teriparatide, abaloparatide, romosozumab, and...